# Safety and Tolerability of EO2002

> **NCT05587205** · PHASE1 · RECRUITING · sponsor: **Asociación para Evitar la Ceguera en México** · enrollment: 32 (estimated)

## Conditions studied

- Cataract
- Endothelial Cell Loss, Corneal

## Interventions

- **BIOLOGICAL:** EO2002
- **OTHER:** Sham injection

## Key facts

- **NCT ID:** NCT05587205
- **Lead sponsor:** Asociación para Evitar la Ceguera en México
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-30
- **Primary completion:** 2026-10-06
- **Final completion:** 2026-10-06
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05587205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05587205, "Safety and Tolerability of EO2002". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05587205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*